Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs and leads to an estimated 230,000 amputations every year in North America and Europe alone to prevent the spread of infection and tissue death. The new therapy could prevent or limit amputations…
Humabs BioMed SA and the Institute for Research in Biomedicine (IRB) affiliated to the Università della Svizzera italiana announced the identification, isolation and characterization of two Ebola virus neutralizing monoclonal antibodies from the blood of a survivor of an Ebola infection.
In patients suffering from Type 1 diabetes, the immune system attacks the pancreas, eventually leaving patients without the ability to naturally control blood sugar. These patients must carefully monitor the amount of sugar in their blood, measuring it several times a day and then injecting themselves with insulin to keep their blood sugar levels within a healthy range. However, precise control…
Tumours kill off surrounding cells to make room to grow, according to new research from the University of Cambridge. Although the study was carried out using fruit flies, its findings suggest that drugs to prevent, rather than encourage, cell death might be effective at fighting cancer – contrary to how many of the current chemotherapy drugs work.
Internet based cognitive behavioural therapy (CBT) can help people affected by body dysmorphic disorder, finds a study published by The BMJ today. This is the largest clinical trial of body dysmorphic disorder ever conducted, and the first to evaluate the effect of an internet based programme for the condition.
Automated latex enhanced immunoturbidimetric H-FABP assay helps emergency departments to detect MI within 30 minutes of chest pain onset, and improve the diagnostic efficiency of Troponin.
Locally applied antibiotics are a component of effective infection management in orthopaedics and trauma surgery. Successful concepts are based on patient-specific surgical and antimicrobial treatment. At the symposium “Infections and high-risk patients: solutions for joint replacements and traumatology” at this year’s Congress on Orthopaedics and Trauma Surgery (DKOU) in Berlin last…
Checkpoint inhibitors can achieve a lasting treatment response in around 20% of some kinds of advanced cancer cases. ‘Immunotherapies are given the highest possible rating on the Magnitude of Clinical Benefit Scale of the European Society for Medical Oncology (ESMO), which assesses the actual clinical benefit of tumour treatments,’ emphasises Professor Christoph Zielinski MD, Head of the…
Following a heart attack or other heart trauma, the heart is unable to replace its dead cells. Patients are often left with little option other than heart transplants, which are rarely available, or more recently cell therapies that transplant heart cells into the patient's heart.
A leading cause of cancer deaths worldwide, colon cancer is famously resistant to treatment. There are many reasons for this, but one has to do with a group of persisting cancer cells in the colon that cause relapses. Conventional therapies against them are mostly ineffective. EPFL scientists have now identified a biological mechanism that can be exploited to counteract colon cancer relapses.
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view of the disease reported in a study from Northwestern Medicine and The University of Chicago.
Findings demonstrate that testosterone is a metabolic hormone as well as a sex hormone, University at Buffalo researchers say.
A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people’s cholesterol levels – and thus their risk of developing heart disease.
In the world of technology, the term Industry 4.0 is already well known. Univ-Prof. Dr. rer. nat. Bernhard Wolf has reveals a comparable development in medicine. Smart systems and personalisation have enormous potential, the Professor for Medical Electronics at the Technical University of Munich is convinced.
Every year, worldwide, over a million patients have a pacemaker or defibrillator implanted. Home monitoring systems can significantly improve the safety and quality of life for these patients, says Professor Gerhard Hindricks, head physician in the rhythmology department at Leipzig’s Heart Centre. Report: Sascha Keutel
First-of-its-kind study by the University of Iowa shows kids with hearing loss benefit from early intervention.
Engineers at the University of California, Berkeley, are developing a new type of bandage. Thanks to advances in flexible electronics, the researchers have created a new "smart bandage" that uses electrical currents to detect early tissue damage from pressure ulcers, or bedsores, before they can be seen by human eyes - and while recovery is still possible.
Warts aren’t just for witches and goblins. According to member dermatologists from the American Academy of Dermatology, children and teens, people who frequently bite their nails, and people with a weakened immune system are more prone to getting warts than others.
A photograph may reveal how something looks, but direct observation can divulge how the objects behave. The difference can mean life or death, especially when it comes to fighting human disease. To help researchers examine exactly how human diseases work at the molecular level, Virginia Tech Carilion Research Institute scientist Deborah Kelly has developed a new set of tools to peer into the…
Hearing loss is one of the most common birth defects, with more than 12,000 children in the United States affected each year. Three students in Wichita State University's biomedical engineering program recognized this issue and designed their senior project to create a therapeutic toy to provide early intervention therapy for children with auditory disabilities.
In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations – mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration. One of the gene mutations also may…
Some six million people in the U.S. suffer from scoliosis, a sideways curvature of the spine. These include approximately 2 to 3% of adolescents who are diagnosed each year with idiopathic scoliosis, which is usually identified during puberty and progresses until skeletal maturity. One in 500 children today require treatment using spine braces and 1 in 5,000 need spinal surgery. The typical spine…
A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system’s killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.
University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments.
People with Parkinson’s disease (PD) tend to slow down and decrease the intensity of their movements even though many retain the ability to move more quickly and forcefully. Now, in proof-of-concept experiments with “joysticks” that measure force, a team of Johns Hopkins scientists report evidence that the slowdown likely arises from the brain’s “cost/benefit analysis,” which gets…